221 related articles for article (PubMed ID: 32468569)
21. A Possible Link Between Parathyroid Hormone Secretion and Local Regulation of GABA in Human Parathyroid Adenomas.
Hong AR; Kim YA; Bae JH; Min HS; Kim JH; Shin CS; Kim SY; Kim SW
J Clin Endocrinol Metab; 2016 Jun; 101(6):2594-601. PubMed ID: 27070188
[TBL] [Abstract][Full Text] [Related]
22. Alterations of DNA methylation in parathyroid tumors.
Guarnieri V; Muscarella LA; Verdelli C; Corbetta S
Mol Cell Endocrinol; 2018 Jul; 469():60-69. PubMed ID: 28501573
[TBL] [Abstract][Full Text] [Related]
23. [Concept, etiology and epidemiology of primary hyperparathyroidism].
Martínez Díaz-Guerra G; Hawkins Carranza F
Endocrinol Nutr; 2009 Apr; 56 Suppl 1():2-7. PubMed ID: 19627754
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of primary hyperparathyroidism.
Cetani F; Pardi E; Borsari S; Marcocci C
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
[TBL] [Abstract][Full Text] [Related]
27. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.
Westin G
J Intern Med; 2016 Dec; 280(6):551-558. PubMed ID: 27071708
[TBL] [Abstract][Full Text] [Related]
29. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.
Cetani F; Marcocci C; Torregrossa L; Pardi E
Endocr Relat Cancer; 2019 Jul; 26(7):R441-R464. PubMed ID: 31085770
[TBL] [Abstract][Full Text] [Related]
30. Are Non-Coding RNAs Useful Biomarkers in Parathyroid Tumorigenesis?
Aurilia C; Donati S; Palmini G; Miglietta F; Falsetti I; Iantomasi T; Brandi ML
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638805
[TBL] [Abstract][Full Text] [Related]
31. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
Marx SJ; Lourenço DM
Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
[TBL] [Abstract][Full Text] [Related]
32. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.
Haven CJ; Howell VM; Eilers PH; Dunne R; Takahashi M; van Puijenbroek M; Furge K; Kievit J; Tan MH; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Dralle H; Hoang-Vu C; Gimm O; Morreau H; Marsh DJ; Teh BT
Cancer Res; 2004 Oct; 64(20):7405-11. PubMed ID: 15492263
[TBL] [Abstract][Full Text] [Related]
33. The role of hyperplasia in multiple parathyroid adenomas.
Larian B; Alavi S; Roesler J; Namazie A; Blackwell K; Calcaterra TC; Wang MB
Head Neck; 2001 Feb; 23(2):134-9. PubMed ID: 11303630
[TBL] [Abstract][Full Text] [Related]
34. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
[TBL] [Abstract][Full Text] [Related]
36. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
[TBL] [Abstract][Full Text] [Related]
37. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
38. A Young Male with Parafibromin-Deficient Parathyroid Carcinoma Due to a Rare Germline HRPT2/CDC73 Mutation.
Kapur A; Singh N; Mete O; Hegele RA; Fantus IG
Endocr Pathol; 2018 Dec; 29(4):374-379. PubMed ID: 30361844
[TBL] [Abstract][Full Text] [Related]
39. Study of parathyroid transcription factor Gcm2 expression in parathyroid lesions.
Nonaka D
Am J Surg Pathol; 2011 Jan; 35(1):145-51. PubMed ID: 21164298
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case.
Omi Y; Horiuchi K; Haniu K; Tokura M; Nagai E; Isozaki O; Nagashima Y; Okamoto T
Endocr J; 2018 Feb; 65(2):245-252. PubMed ID: 29225207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]